AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NASDAQ:FPRXFive Prime Therapeutics Earnings Date, Estimates & History

$5.94
-0.05 (-0.83 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.58
Now: $5.94
$6.11
50-Day Range
$2.14
MA: $3.46
$5.43
52-Week Range
$1.75
Now: $5.94
$9.13
Volume429,400 shs
Average Volume407,707 shs
Market Capitalization$217.61 million
P/E RatioN/A
Dividend YieldN/A
Beta2.78

Earnings

Five Prime Therapeutics (NASDAQ:FPRX) Earnings Information

Five Prime Therapeutics last announced its earnings data on May 7th, 2020. The biotechnology company reported ($0.57) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.67) by $0.10. The business earned $8.41 million during the quarter, compared to analyst estimates of $6.60 million. Five Prime Therapeutics has generated ($3.92) earnings per share over the last year. Five Prime Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 5th, 2020 based off prior year's report dates.

Five Prime Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Five Prime Therapeutics (NASDAQ:FPRX) Earnings Estimates

2020 EPS Consensus Estimate: ($3.07)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.96)($0.80)($0.88)
Q2 20203($0.81)($0.74)($0.78)
Q3 20203($0.82)($0.65)($0.74)
Q4 20203($0.84)($0.48)($0.68)

Five Prime Therapeutics (NASDAQ FPRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/5/2020
(Estimated)
       
5/7/20203/31/2020($0.67)($0.57)($0.57)$6.60 million$8.41 millionTranscript
2/27/2020Q4 2019($0.97)($0.89)($0.89)$4.05 million$3.21 millionTranscript
11/6/2019Q3($0.95)($1.03)($1.03)$4.33 million$2.98 millionTranscript
8/7/2019Q2 2019($0.90)($0.99)($0.99)$5.53 million$3.33 millionN/A
5/8/2019Q1($1.07)($1.02)($1.02)$5.71 million$5.35 millionN/A
2/26/2019Q4 2018($1.30)($1.12)($1.12)$8.06 million$4.03 millionN/A
11/6/2018Q3($1.15)($1.37)($1.37)$7.45 million$5.77 millionN/A
8/8/2018Q2($1.29)($0.99)($0.99)$5.87 million$7.58 millionN/A
5/8/2018Q1 2018($0.55)($0.63)($0.63)$37.50 million$32.49 millionN/A
2/27/2018Q4 2017($1.29)($1.04)($1.04)$9.86 million$13.22 millionN/A
11/6/2017Q3 2017($1.3520)($1.5450)($1.54)$16.16 million$8.33 millionN/A
8/8/2017Q2 2017($1.15)($1.58)($1.58)$8.32 million$7.80 millionListen
5/4/2017Q1 2017($1.01)($1.21)($1.21)$6.05 million$10.13 millionListen
2/23/2017Q4 2016($0.57)($0.73)($0.73)$7.09 million$8.30 millionN/A
11/3/2016Q3($0.51)($0.72)($0.72)$7.50 million$6.70 millionN/A
8/4/2016Q2($0.56)($0.49)($0.49)$6.38 million$9.23 millionN/A
5/5/2016Q1($0.71)($0.49)($0.49)$5.26 million$6.50 millionN/A
3/10/2016Q4$9.67$10.63$10.63$354.16 million$363.34 millionListen
11/4/2015Q315($0.99)($0.93)($0.93)$4.90 million$5.90 millionN/A
8/6/2015Q215($0.44)($0.45)($0.45)$6.92 million$6.30 millionN/A
5/13/2015Q1($0.46)($0.44)($0.44)$4.77 million$4.30 millionListen
3/17/2015Q414($0.40)($0.55)($0.55)$5.39 million$4.65 millionN/A
11/10/2014Q3 2014($0.40)($0.33)($0.33)$5.22 million$6.06 millionN/A
8/5/2014Q2 14($0.27)($0.46)($0.46)$5.39 million$4.98 millionN/A
5/8/2014Q1 2014($0.37)($0.46)($0.46)N/A
3/25/2014Q4 2013($0.60)($0.43)($0.43)$1.52 million$3.79 millionListen
11/12/2013Q3 2013($0.57)($2.74)($2.74)$2.50 million$3.48 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.